comparemela.com

Latest Breaking News On - Global generics - Page 11 : comparemela.com

Financial Analysis: Dr Reddy s Laboratories (NYSE:RDY) vs LAVA Therapeutics (NASDAQ:LVTX)

Financial Analysis: Dr Reddy s Laboratories (NYSE:RDY) vs LAVA Therapeutics (NASDAQ:LVTX)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Head to Head Review: Dr Reddy s Laboratories (NYSE:RDY) versus LAVA Therapeutics (NASDAQ:LVTX)

LAVA Therapeutics (NASDAQ:LVTX – Get Free Report) and Dr. Reddy’s Laboratories (NYSE:RDY – Get Free Report) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, profitability, institutional ownership and earnings. Analyst Ratings This is a breakdown of […]

Janiczek Wealth Management LLC Purchases 330 Shares of Dr Reddy s Laboratories Limited (NYSE:RDY)

Janiczek Wealth Management LLC grew its position in Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 10.8% in the second quarter, Holdings Channel.com reports. The fund owned 3,392 shares of the company’s stock after buying an additional 330 shares during the period. Janiczek Wealth Management LLC’s holdings in Dr. Reddy’s Laboratories were worth $214,000 […]

Dr Reddy s Laboratories Limited (NYSE:RDY) Shares Sold by Allspring Global Investments Holdings LLC

Allspring Global Investments Holdings LLC cut its stake in Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) by 0.3% during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 108,167 shares of the company’s stock after selling 281 shares during the period. Allspring Global Investments Holdings LLC’s […]

Natixis Advisors L P Takes Position in Dr Reddy s Laboratories Limited (NYSE:RDY)

Natixis Advisors L.P. acquired a new position in shares of Dr. Reddy’s Laboratories Limited (NYSE:RDY – Free Report) in the 1st quarter, according to the company in its most recent filing with the SEC. The fund acquired 26,013 shares of the company’s stock, valued at approximately $1,481,000. A number of other hedge funds and other […]

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.